Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,134 recalls, newest first

Class II · Moderate risk

Acarbose Tablets

Labeling: Incorrect or Missing Lot and/or Exp Date: An incorrect expiration date of July 2018 is printed on the product labeling rather than the correct expiration date of July 2017.

Terminated Labeling / mix-up Teva Pharmaceuticals USA NDC 16252-523-01 D-1178-2017
Class III · Low risk

Phentermine

Failed Impurities/Degradation Specification; out-of-specification results for individual unknown impurities at the 30 month Room Temperature Retained Sample stability test

Terminated Temperature excursion Aidarex Pharmaceuticals LLC D-1162-2017
Class II · Moderate risk

Sterile Eyewash

Lack of sterility assurance: leaking containers which could lead to exposure to infectious agents.

Terminated Sterility / contamination Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company D-0160-2018
Class II · Moderate risk

Sterile Eyewash

Lack of sterility assurance: leaking containers which could lead to exposure to infectious agents.

Terminated Sterility / contamination Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company D-0159-2018
Class II · Moderate risk

Sterile Eyewash

Lack of sterility assurance: leaking containers which could lead to exposure to infectious agents.

Terminated Sterility / contamination Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company D-0158-2018
Class II · Moderate risk

Sterile Eyewash

Lack of sterility assurance: leaking containers which could lead to exposure to infectious agents.

Terminated Sterility / contamination Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company D-0157-2018
Class II · Moderate risk

Urin D/S Tablets Methenamine 81.6 mg

Superpotent Drug: Subpotent Drug. FDA analysis found this product to be Out of Specification for assay which could result in either Subpotent and/or Superpotent tablets.

Terminated Wrong potency / content Llorens Pharmaceutical Corp. D-0081-2018
Class III · Low risk

ENALAPRIL MALEATE Tablets

Failed Impurities/Degradation Specifications: manufacturer of product recalled this repackaged lot due to out of specification results for related compound.

Terminated Impurity / degradation Aidarex Pharmaceuticals LLC NDC 33261-0693-90 D-0053-2018

Recalls by year